Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Durai Sundar

Showing results (71-80 of 114) with videos related to

Pageof 12
Sort By:
Frontiers in Molecular Biosciences|January 26, 2024
Computational analysis of RNA methyltransferase Rv3366 as a potential drug target for combating drug-resistant <i>Mycobacterium tuberculosis</i>Tasmin Nazim, Vipul Kumar, Faraz Ahmed, et al.
Antimicrobial Agents and Chemotherapy|October 15, 2014
Probing the molecular mechanism of hypericin-induced parasite death provides insight into the role of spermidine beyond redox metabolism in Leishmania donovaniShalini Singh, Shyamali Sarma, Shashank P Katiyar, et al.
Journal of Biomolecular Structure & Dynamics|November 29, 2024
Investigating the interaction pattern of FDA approved compounds with <i>Mycobacterium tuberculosis</i> GidB to understand their potential as antibioticsTasmin Nazim, Vipul Kumar, Faraz Ahmed, et al.
Peerj|November 8, 2019
The complete chloroplast genome of <i>Dendrobium nobile</i>, an endangered medicinal orchid from north-east India and its comparison with related <i>Dendrobium</i> speciesRuchishree Konhar, Manish Debnath, Santosh Vishwakarma, et al.
Frontiers in Genetics|October 28, 2021
Genetic Risk Prediction of COVID-19 Susceptibility and Severity in the Indian PopulationP Prakrithi, Priya Lakra, Durai Sundar, et al.
Cancers|March 6, 2021
Identification and Characterization of Mortaparib<sup>Plus</sup>-A Novel Triazole Derivative That Targets Mortalin-p53 Interaction and Inhibits Cancer-Cell Proliferation by Wild-Type p53-Dependent and -Independent MechanismsAnissa Nofita Sari, Ahmed Elwakeel, Jaspreet Kaur Dhanjal, et al.
Plos One|August 5, 2015
Computational Structure-Based De Novo Design of Hypothetical Inhibitors against the Anti- Inflammatory Target COX-2Jaspreet Kaur Dhanjal, Anith Kumar Sreenidhi, Khushboo Bafna, et al.
Current Topics in Medicinal Chemistry|July 27, 2023
Effect of Withaferin-A, Withanone, and Caffeic Acid Phenethyl Ester on DNA Methyltransferases: Potential in Epigenetic Cancer TherapyVipul Kumar, Jaspreet Kaur Dhanjal, Anissa Nofita Sari, et al.
Scientific Reports|November 24, 2019
2, 3-Dihydro-3β-methoxy Withaferin-A Lacks Anti-Metastasis Potency: Bioinformatics and Experimental EvidencesAnupama Chaudhary, Rajkumar S Kalra, Vidhi Malik, et al.
Journal of Experimental & Clinical Cancer Research : CR|December 21, 2019
Mortaparib, a novel dual inhibitor of mortalin and PARP1, is a potential drug candidate for ovarian and cervical cancersJayarani F Putri, Priyanshu Bhargava, Jaspreet Kaur Dhanjal, et al.
Pageof 12

Showing results (71-80 of 114) with videos related to

Sort By:
Pageof 12
Frontiers in Molecular Biosciences|January 26, 2024
Computational analysis of RNA methyltransferase Rv3366 as a potential drug target for combating drug-resistant <i>Mycobacterium tuberculosis</i>Tasmin Nazim, Vipul Kumar, Faraz Ahmed, et al.
Antimicrobial Agents and Chemotherapy|October 15, 2014
Probing the molecular mechanism of hypericin-induced parasite death provides insight into the role of spermidine beyond redox metabolism in Leishmania donovaniShalini Singh, Shyamali Sarma, Shashank P Katiyar, et al.
Journal of Biomolecular Structure & Dynamics|November 29, 2024
Investigating the interaction pattern of FDA approved compounds with <i>Mycobacterium tuberculosis</i> GidB to understand their potential as antibioticsTasmin Nazim, Vipul Kumar, Faraz Ahmed, et al.
Peerj|November 8, 2019
The complete chloroplast genome of <i>Dendrobium nobile</i>, an endangered medicinal orchid from north-east India and its comparison with related <i>Dendrobium</i> speciesRuchishree Konhar, Manish Debnath, Santosh Vishwakarma, et al.
Frontiers in Genetics|October 28, 2021
Genetic Risk Prediction of COVID-19 Susceptibility and Severity in the Indian PopulationP Prakrithi, Priya Lakra, Durai Sundar, et al.
Cancers|March 6, 2021
Identification and Characterization of Mortaparib<sup>Plus</sup>-A Novel Triazole Derivative That Targets Mortalin-p53 Interaction and Inhibits Cancer-Cell Proliferation by Wild-Type p53-Dependent and -Independent MechanismsAnissa Nofita Sari, Ahmed Elwakeel, Jaspreet Kaur Dhanjal, et al.
Plos One|August 5, 2015
Computational Structure-Based De Novo Design of Hypothetical Inhibitors against the Anti- Inflammatory Target COX-2Jaspreet Kaur Dhanjal, Anith Kumar Sreenidhi, Khushboo Bafna, et al.
Current Topics in Medicinal Chemistry|July 27, 2023
Effect of Withaferin-A, Withanone, and Caffeic Acid Phenethyl Ester on DNA Methyltransferases: Potential in Epigenetic Cancer TherapyVipul Kumar, Jaspreet Kaur Dhanjal, Anissa Nofita Sari, et al.
Scientific Reports|November 24, 2019
2, 3-Dihydro-3β-methoxy Withaferin-A Lacks Anti-Metastasis Potency: Bioinformatics and Experimental EvidencesAnupama Chaudhary, Rajkumar S Kalra, Vidhi Malik, et al.
Journal of Experimental & Clinical Cancer Research : CR|December 21, 2019
Mortaparib, a novel dual inhibitor of mortalin and PARP1, is a potential drug candidate for ovarian and cervical cancersJayarani F Putri, Priyanshu Bhargava, Jaspreet Kaur Dhanjal, et al.
Pageof 12